Prevention and Treatment of Pyrrolitinib-associated Diarrhea

NCT04736186 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

470

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Loperamide
DRUG: Loperamide and golden bifid
DRUG: Loperamide and montmorillonite powder

Sponsor

Tianjin Medical University Cancer Institute and Hospital